Bunch Paul M, Nguyen Christopher J, Johansson Erik D, Randle Reese W
Department of Radiology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157.
Department of Radiology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157.
Acad Radiol. 2023 May;30(5):881-890. doi: 10.1016/j.acra.2022.05.014. Epub 2022 Jun 25.
Gaps in primary hyperparathyroidism diagnosis are well-documented. End-organ damage correlates with disease duration and often occurs before diagnosis. We hypothesize that opportunistic parathyroid gland assessment on routine CT could decrease existing diagnosis gaps. Our purpose is to assess for enlarged parathyroid glands on contrast-enhanced CT acquired prior to biochemical screening and subsequent development of related morbidity.
This retrospective study included consecutive patients with primary hyperparathyroidism undergoing parathyroidectomy with contrast-enhanced CT including the lower neck and upper chest acquired prior to biochemical screening. One neuroradiologist retrospectively evaluated all CTs for enlarged (estimated weight greater than 60 mg) parathyroid glands. Gold standard operative and pathology reports were correlated with CT findings, and medical records were reviewed for development of primary hyperparathyroidism-related comorbidities.
The sample comprised 38 patients (30 women, 8 men, median age 60 years) with 70 CTs of interest. The neuroradiologist identified 32 putative enlarged parathyroid glands (median estimated weight 307 mg) in 29 (76%) patients on CTs predating biochemical screening by a median of 30 months. Putative enlarged parathyroid glands on CT corresponded to pathologically proven parathyroid lesions in 26 (90%) patients. Of 26 patients with retrospectively identified pathologically proven parathyroid lesions, 12 (46%) developed at least 1 renal, bone, or neurocognitive comorbidity between CT and subsequent biochemical screening.
Enlarged parathyroid glands are frequently visible on routine CTs acquired years prior to primary hyperparathyroidism diagnosis. Biochemical screening based on enlarged glands could potentially prevent associated morbidity in almost half of such patients.
原发性甲状旁腺功能亢进症诊断中的差距已有充分记录。终末器官损害与疾病持续时间相关,且常在诊断之前就已出现。我们假设在常规CT检查时进行机会性甲状旁腺评估可以减少现有的诊断差距。我们的目的是在生化筛查及相关疾病发生之前,通过对比增强CT评估甲状旁腺是否肿大。
这项回顾性研究纳入了连续接受甲状旁腺切除术的原发性甲状旁腺功能亢进症患者,这些患者在生化筛查之前进行了包括下颈部和上胸部的对比增强CT检查。一名神经放射科医生对所有CT进行回顾性评估,以确定甲状旁腺是否肿大(估计重量超过60毫克)。将金标准手术和病理报告与CT结果进行关联,并查阅病历以了解原发性甲状旁腺功能亢进症相关合并症的发生情况。
样本包括38例患者(30名女性,8名男性,中位年龄60岁),共70次感兴趣的CT检查。神经放射科医生在生化筛查前中位时间30个月的CT检查中,在29例(76%)患者中发现了32个疑似肿大的甲状旁腺(中位估计重量307毫克)。CT上疑似肿大的甲状旁腺在26例(90%)患者中与病理证实的甲状旁腺病变相对应。在26例经回顾性确定有病理证实的甲状旁腺病变的患者中,12例(46%)在CT检查至随后的生化筛查期间出现了至少1种肾脏、骨骼或神经认知合并症。
在原发性甲状旁腺功能亢进症诊断前数年进行的常规CT检查中,经常可以看到肿大的甲状旁腺。基于甲状旁腺肿大进行生化筛查可能会预防近一半此类患者的相关疾病。